tirzepatide alzheimer's clinical trial Demonstrates Sustained Weight Loss but Discontinuation Results in Weight Regain: SURMOUNT-4 Tirzepatide after intensive lifestyle intervention

Nooms flagship behavior change program, Noom Weight, is generally available if you are over 18 years old and have a BMI greater than 18.5 (not underweight)

The development of high-dose GLP-1 receptor agonists and the dual GLP-1/GIP receptor agonist tirzepatide resulted in increasing numbers of people reaching HbA1c and body weight targets, with up to 62% attaining normoglycemia with 15-mg tirzepatide [27]

When combined with B vitamins, this blend enhances everything from cellular energy production to appetite control, while supporting fat-burning, liver health, and overall metabolic function

These drugs mimic a digestive hormone called glucagon-like peptide 1 (ergo, GLP-1), which helps lower blood sugar and suppress appetite